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 Abstract  Loss of E-cadherin function has been reported to be associated with 
progression and poor prognosis of liver cancer. However, the precise role of 
E-cadherin in liver cancer development has not been elucidated. Thus, we generated 
liver- speciﬁ c E-cadherin ( Cdh1 ) knockout mice ( Cdh1 ∆ Liv  ) by crossing  Cdh1  fl ox/fl ox  
mice with  albumin-Cre transgenic mice. Interestingly,  Cdh1 ∆ Liv  mice developed 
spontaneous inﬂ ammation in the portal areas, and then developed periductal onion 
skin–like ﬁ brosis, which resembled primary sclerosing cholangitis. Microarray 
analysis showed that expression of stem cell markers such as CD44 and Sox9, 
and inﬂ ammatory cytokines such as IL-6 and TNF-α, are increased in  Cdh1 ∆ Liv  
liver compared with  Cdh1  fl ox/fl ox  liver. To investigate the role of E-cadherin in the 
liver tumorigenesis, we crossed  Cdh1 ∆ Liv  mice with  lox-stop-lox Kras  G12D  mice 
( Kras + Cdh1 ∆ Liv  ).  Kras + Cdh1 ∆ Liv  mice developed liver tumors at age 28 weeks 
(8/8, 100 %), whereas  Kras + Cdh1  fl ox/+  mice did not develop any tumors. 
Histologically, these tumors were hepatocellular carcinomas with a small proportion 
of ductal lesions and strongly positive for progenitor cell markers such as CD44 
and Sox9. Interestingly, epithelial to mesenchymal transition (EMT) was found in 
the tumors of  Kras + Cdh1 ∆ Liv  mice. We also found that diethylnitrosamine-induced 
tumorigenesis was signiﬁ cantly accelerated in  Cdh1 ∆ Liv  mice. In summary, loss of 
E-cadherin in the liver leads to sclerosing cholangitis and promotes tumorigenesis. 
Its tumor- promoting function seemed to be caused by gain of stem cell properties as 
well as induction of EMT. 
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 Introduction 
 Hepatocellular carcinoma (HCC) is the third most common cause of cancer deaths 
worldwide; therefore, improving the prognosis has become an important issue [ 1 ]. 
Major HCC risk factors include infection with hepatitis B (HBV) or C viruses 
(HCV), alcohol and non-alcoholic steatohepatitis (NASH). The prognosis of 
patients with HCC has improved recently because of progress in early diagnosis and 
treatment, but patients with advanced HCC are still incurable. Thus, understanding 
the carcinogenic mechanisms and exploring new therapeutic targets for HCC has 
become an important issue. 
 Hanahan et al. showed that all cancers share common hallmarks such as prolif-
eration or anti-cell death that govern the transformation of normal cells to cancer 
cells [ 2 ]. Among them, invasion and metastasis play important roles in tumor 
promotion and progression, and are associated with prognosis of the patients. 
Dysregulation of E-cadherin has been reported to contribute to cancer progression [ 3 ]. 
It is reported that decreased expression of E-cadherin is associated with malignant 
progression in various kinds of cancer, such as gastric cancer or skin cancer [ 4 ]. 
In liver cancers, HCC or cholangiocarcinoma (CCC), E-cadherin expression is 
decreased by 20–60 % and is associated with invasiveness or poor prognosis [ 5 ,  6 ]. 
These ﬁ ndings suggest that E-cadherin may play an important role in tumor 
suppression in the liver. However, so far, the precise roles of E-cadherin in liver 
carcinogenesis remain unclear, especially in vivo; thus, we examined the role of 
E-cadherin in liver tumorigenesis by using liver-speciﬁ c E-cadherin knockout mice. 
 Results 
 Physiological Function of E-cadherin in the Liver 
 To determine the role of E-cadherin in the liver, we generated liver-speciﬁ c 
E-cadherin knockout mice by crossing  Cdh1  F/F  and albumin-Cre transgenic mice 
(both from Jackson Laboratories). In  Cdh1  F/F  control mice, E-cadherin was 
expressed on the membrane of hepatocytes and interlobular biliary epithelial cells. 
In contrast, in  Cdh1 Δ L  mice, the expression was completely deleted in both hepato-
cytes and biliary epithelial cells (Fig.  1a ). Histologically,  Cdh1 Δ L  liver was shown to 
be almost normal at 1 month; however, at 2 month of age,  Cdh1 Δ L  mice spontane-
ously developed inﬂ ammation around the portal area, and at 8 month of age, 
periductal onion skin–like ﬁ brosis, which resembled human primary sclerosing 
cholangitis, was observed in  Cdh1 Δ L  mice (Fig.  1b ).
 According to the periductal inﬂ ammation, we hypothesized that the bile trans-
port system might be impaired by the E-cadherin deletion from the biliary epithelial 
cells. To prove the hypothesis, ﬂ uorescent-labeled bile acid was injected into 
 Cdh1  F/F  and  Cdh1 ∆ L  mice. After 15 min, in control  Cdh1  F/F  mice, we could see a 
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clear canalicular pattern and bile acid was smoothly transported into the bile duct. 
In contrast, in  Cdh1 ∆ L  mice, the canalicular staining pattern was very fuzzy and bile 
acid did not reach the bile duct lumen. These observations suggest that the bile 
canalicular network may be functionally impaired in  Cdh1 ∆ L  mice, and this leads to 
liver injury and subsequent inﬂ ammation. 
 Progenitor Cell Proliferation in  CDH1 Δ L  Mice 
 To characterize the phenotype of  CDH1 Δ L  mice, microarray analysis was performed 
using whole-liver samples obtained from  CDH1  F/F  and  CDH1 Δ L  mice. The expres-
sion of several hepatic progenitor cell markers, such as Sox9, CD44, or Epcam, was 
upregulated in  CDH1 Δ L  mice compared with  CDH1  F/F  mice. The results were con-
ﬁ rmed by immunohistochemical analysis in  CDH1  F/F  and  CDH1 Δ L  mice. We also 
found a lot of ductal cells expressing these progenitor cell markers in the periportal 
area. These results suggest that ductal cells with progenitor potential are proliferating 
in the portal area of  CDH1 Δ L  mice. 
 Fig. 1  ( a ) Analysis of E-cadherin expression by immunohistochemistry of liver sections (×200) 
obtained from 1-month-old  CDH1  F/F  and  CDH1 Δ L  mice. ( b ) H&E staining of 2-, 5-, and 8-month- 
old  CDH1 Δ L  mice (×200) 
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 Loss of E-cadherin Accelerates Oncogene-Addicted 
Liver Carcinogenesis 
 Because Ras signaling is frequently active in human HCC, we crossed  CDH1 Δ L  
mice with active  Kras conditional knockin ( LSL-Kras  G12D  ) mice ( Kras/CDH1 Δ L  ). 
All male  Kras/CDH1 Δ L  mice developed multiple liver tumors at 8 months of age 
( n = 10), whereas only 4 of 10 male albumin-Cre/ LSL - Kras  G12D  /CDH1 wild-type 
mice ( Kras/CDH1  +/+  ) developed a few visible tumors (Fig.  2a ). Most of the tumors 
arising in  Kras/CDH1 Δ L  mice were AFP-positive HCC and ranged from a well to a 
poorly differentiated type. On the other hand, tumors in the  Kras/CDH1  +/+  mice 
were mostly AFP-negative dysplastic nodules or well-differentiated HCC. These 
results suggest that loss of E-cadherin accelerates Ras-addicted liver cancer 
development.
 We assessed activation of extracellular signal-regulated kinase (ERK), which is 
a major downstream transducer of Ras, in non-tumor tissue. Strong ERK phos-
phorylation was observed in  Kras/CDH1 Δ L  livers compared with that in  Kras/
CDH1  +/+  livers. We thought that the increased ERK activation was one of the mech-
anism for the tumor acceleration in  CDH1 Δ L  mice. 
 Epithelial to mesenchymal transition (EMT) is considered a key process for 
tumor invasiveness, and loss of E-cadherin expression is a hallmark of EMT [ 7 ]. 
Interestingly, in some tumors in  Kras/CDH1 Δ L  mice, HCC cells gradually trans-
formed into ﬁ broblast-like cells, and these cells were positive for the mesenchymal 
marker vimentin, indicating that spontaneous EMT occurred in the tumors of these 
mice. EMT was shown to be associated with a gain of stem cell properties [ 7 ]. 
Indeed, evident expression of two stem cell markers, CD44 and Sox9, was positive 






















 Fig. 2  ( a ) Representative images of the liver from 8-month-old  Kras/CDH1  +/+  and  Kras/CDH1 Δ L  
mice. ( b ) Bar graphs of tumor number and tumor size in each mouse after 8 months of diethylni-
trosamine (DEN) injections are shown. Data are expressed as means ± SEMs ( n = 10 per group, 
* p < 0.05) 
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 In female  Kras/CDH1 Δ L  mice, only two of eight mice developed tumors by 
12 months of age. This indicates gender disparity in this model of liver cancer 
susceptibility, as was shown in other mouse HCC models [ 8 ]. 
 Loss of E-cadherin Promotes Chemical-Induced HCC 
 To further examine the role of E-cadherin in hepatocarcinogenesis, we used 
diethylnitrosamine (DEN) to induce a hepatocyte-derived HCC [ 9 ].  CDH1  F/F  mice 
and  CDH1 Δ L  mice were injected with 25 mg/kg DEN on postnatal day 14 [ 10 ]. 
After 8 months,  CDH1 Δ L  mice showed a signiﬁ cantly increased number and size of 
liver tumors compared with  CDH1  F/F  mice. In addition,  CDH1 Δ L  mice developed 
histologically more advanced tumors (Fig.  2b ). As in  Kras/CDH1 Δ L  mice, strong 
ERK phosphorylation was observed in tumors of DEN-treated  CDH1 Δ L  mice. Some 
tumors in  CDH1 Δ L  mice strongly expressed CD44 and vimentin, whereas very few 
tumors in  CDH1  F/F  mice expressed these markers. These results conﬁ rmed that loss 
of E-cadherin enhances activation of ERK and expression of stem cell and EMT 
markers in a chemically induced HCC model. 
 Relationship Between E-cadherin Loss and Mesenchymal 
and Stem Cell Markers in Human HCC 
 To investigate whether E-cadherin loss correlates with mesenchymal and stem cell 
markers in human HCC, we examined the expression of E-cadherin, CD44, and 
vimentin in human HCC cell lines. Signiﬁ cant inverse correlations were observed, 
particularly between E-cadherin and CD44. Among these cell lines, we chose three 
that expressed E-cadherin, Hep3B, HuH7, and PLC/PRF/5, and we examined the 
effect of E-cadherin knockdown with siRNA. All three cell lines exhibited elevated 
expression of mesenchymal markers such as N-cadherin and vimentin, and showed 
an elongated mesenchymal-like appearance. In addition, invasion capacity was sig-
niﬁ cantly increased by E-cadherin knockdown, suggesting that loss of E-cadherin 
can be a causal factor of EMT and invasive phenotype of HCC. 
 Discussion 
 Our current data strongly suggest that E-cadherin is a tumor suppressor in the liver. 
Although various kinds of epithelial tumors showed decreased E-cadherin expres-
sion, there have been few reports of direct connections between E-cadherin loss and 
tumor progression, especially in vivo [ 11 ,  12 ]. In this study, when combined with 
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Ras activation or chemical carcinogen administration,  CDH1 Δ L  display markedly 
accelerated carcinogenesis and an invasive phenotype. Although it has been unclear 
whether loss of E-cadherin is a consequence or a cause of EMT, we have demon-
strated its causal role in vivo and in vitro. Recent reports have established a direct 
link between EMT and a gain of stem/progenitor cell properties [ 7 ], which is sup-
ported by our mouse models since tumor cells undergoing EMT clearly expressed 
stem cell markers. The expression of stem cell markers such as CD44 and Sox9 has 
been reported to be associated with a poor prognosis in patients with HCC [ 13 ]. 
 The cellular source of liver cancers still remains unclear. Recent studies 
suggested that mature hepatocytes could translate into not only HCC but also 
CCC [ 14 ]. We speculated that tumors in  Kras/CDH1 Δ L  mice originated from two 
different cell types on the basis of the pathological ﬁ ndings and distribution of 
the tumors—proliferating duct cells including progenitor cells induced by loss of 
E-cadherin, and mature hepatocytes transformed by Ras activation. However, to 
reach a ﬁ rm conclusion, further analyses such as cell lineage tracing are needed, and 
we consider this an important future issue. 
 In summary, loss of E-cadherin in the liver causes impairment of the intrahepatic 
biliary network and subsequent inﬂ ammatory reactions. In mature hepatocytes, loss 
of E-cadherin leads to EMT induction, upregulation of stem cell markers, and ERK 
activation, which eventually results in enhanced carcinogenesis and an invasive 
phenotype [ 15 ]. Thus, E-cadherin plays critical roles in maintaining homeostasis 
and suppressing carcinogenesis in the liver. 
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